[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

July 2019 - April 2016

Decade

Year

Issue

April 2016, Vol 1, No. 1, Pages 1-108

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):1. doi:10.1001/jamacardio.2015.0002
Original Investigation

Development and Validation of Risk Prediction Models for Cardiovascular Events in Black Adults: The Jackson Heart Study Cohort

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):15-25. doi:10.1001/jamacardio.2015.0300

This study develops and validates risk prediction models from the Jackson Heart Study for cardiovascular disease incidence in black adults, incorporating standard risk factors, biomarkers, and subclinical disease.

Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):26-35. doi:10.1001/jamacardio.2015.0304

This study uses data from the Framingham Heart Study to evaluate the effect of prepregnancy elevation of low-density lipoprotein cholesterol levels on the development of dyslipidemia in adult offspring.

Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):37-45. doi:10.1001/jamacardio.2015.0275

This study evaluates hospital-level variation to determine whether hospital process composite performance measures of in-hospital cardiac arrest care quality are associated with patient outcomes.

Development and Validation of a Risk Prediction Model for In-Hospital Mortality After Transcatheter Aortic Valve Replacement

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):46-52. doi:10.1001/jamacardio.2015.0326

This study uses Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry data to develop a statistical model for prediction of in-hospital mortality after transcatheter aortic valve replacement in a national population of patients undergoing the procedure.

Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry

Abstract Full Text
free access has audio
JAMA Cardiol. 2016;1(1):55-62. doi:10.1001/jamacardio.2015.0374

This cross-sectional study of outpatients with atrial fibrillation enrolled in the NCDR PINNACLE Registry examines the extent to which prescription of an oral anticoagulant in real-world US cardiology practices increases as the number of stroke risk factors increases.

Incidence and Determinants of Traumatic Intracranial Bleeding Among Older Veterans Receiving Warfarin for Atrial Fibrillation

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):65-72. doi:10.1001/jamacardio.2015.0345

This cohort study at the Department of Veterans Affairs describes the incidence of and risk factors for traumatic intracranial bleeding in a large cohort of older adults who were newly prescribed warfarin sodium.

Sudden Cardiac Death After Non–ST-Segment Elevation Acute Coronary Syndrome

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):73-79. doi:10.1001/jamacardio.2015.0359

This pooled cohort analysis of data on 48 286 patients in 4 randomized clinical trials investigates the incidence of sudden cardiac death after non–ST-segment elevation acute coronary syndrome (ACS) to develop a risk model and score for sudden cardiac death.

Athletic Cardiac Remodeling in US Professional Basketball Players

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):80-87. doi:10.1001/jamacardio.2015.0252

This cohort study assesses the echocardiographic records and cardiac structural variables of National Basketball Association professional athletes.

Prevalence of Subclinical Rheumatic Heart Disease in Eastern Nepal: A School-Based Cross-sectional Study

Abstract Full Text
open access
JAMA Cardiol. 2016;1(1):89-96. doi:10.1001/jamacardio.2015.0292

This study determines the prevalence of clinically silent and manifest rheumatic heart disease as a function of age, sex, and socioeconomic status and estimates age-specific incidence.

Viewpoint

Treatment of Heart Failure With Preserved Ejection Fraction: Reflections on Its Treatment With an Aldosterone Antagonist

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):7-8. doi:10.1001/jamacardio.2015.0356

This Viewpoint discusses management of heart failure with preserved ejection fraction (HFpEF) and lessons learned from the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial.

Moving From Disease-Centered to Patient Goals–Directed Care for Patients With Multiple Chronic Conditions: Patient Value-Based Care

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):9-10. doi:10.1001/jamacardio.2015.0248

This Viewpoint discusses patient goals–directed care as an alternative to disease-centered decision making to better align care with what matters most to patients and reduces treatment burden.

Editorial

JAMA Cardiology: A New Cardiovascular Journal

Abstract Full Text
free access has multimedia has audio
JAMA Cardiol. 2016;1(1):11-12. doi:10.1001/jamacardio.2015.0358

The Pooled Cohort Risk Equations—Black Risk Matters

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):12-14. doi:10.1001/jamacardio.2015.0323
Invited Commentary

Predicting Outcomes in Individual Patients After Transcatheter Aortic Valve Replacement: Small Steps on the Path to Improved Decision Making

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):53-54. doi:10.1001/jamacardio.2016.0006

Preventing Stroke in Patients With Atrial Fibrillation—A Steep Climb Away From Achieving Peak Performance

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):63-64. doi:10.1001/jamacardio.2015.0382

Cardiac Variables in Professional Basketball Players: Looking Closely at the Normal Big Athlete (NBA)

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):87-88. doi:10.1001/jamacardio.2015.0289

Screening for Rheumatic Heart Disease in Eastern Nepal

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):96-97. doi:10.1001/jamacardio.2015.0303
Review

How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):98-105. doi:10.1001/jamacardio.2015.0354

This review discusses the treatment advances that are now available to patients with hypertrophic cardiomyopathy and that have reduced disease-related mortality and improved quality of life.

JAMA Cardiology Clinical Challenge

Disabling Palpitations in an Adolescent

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):107-108. doi:10.1001/jamacardio.2015.0284

A teenage girl presents with recurrent episodes of palpitations for 6 consecutive years, with right bundle branch block morphologic features that did not improve with sotalol treatment. What would you do next?

Editor's Note

Nurturing Nature—Exploring the Possible Role of Epigenetics in Dyslipidemia

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):36. doi:10.1001/jamacardio.2015.0302
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2016;1(1):2. doi:10.1001/jamacardio.2015.0003
×